Table 1 Patients’ characteristics stratified by alcohol consumption classification at baseline
Baseline characteristics | Abstainers (N = 3422) | Moderate (N = 2279) | Hazardous (N = 637) | Total (N = 6338) |
|---|---|---|---|---|
Gender, n(%) | ||||
Male | 2363 (69.1%) | 1954 (85.7%) | 567 (89.0%) | 4884 (77.1%) |
Female | 1059 (30.9%) | 325 (14.3%) | 70 (11.0%) | 1454 (22.9%) |
Age, years | ||||
Median (IQR) | 38 (31, 47) | 37 (30, 45) | 41 (34, 49) | 38 (31, 46) |
Mode of HIV Transmission, n(%) | ||||
PWID | 367 (10.7%) | 250 (11.0%) | 114 (17.9%) | 731 (11.5%) |
Homosexual contacts | 1317 (38.5%) | 1124 (49.3%) | 222 (34.9%) | 2663 (42.0%) |
Heterosexual contacts | 1517 (44.3%) | 757 (33.2%) | 269 (42.2%) | 2543 (40.1%) |
Other/Unknown | 221 (6.5%) | 148 (6.5%) | 32 (5.0%) | 401 (6.3%) |
Nationality, n(%) | ||||
Italian | 2572 (75.2%) | 1915 (84.0%) | 516 (81.0%) | 5003 (78.9%) |
Region, n(%) | ||||
North | 1577 (46.1%) | 1144 (50.2%) | 382 (60.0%) | 3103 (49.0%) |
Center | 1366 (39.9%) | 866 (38.0%) | 217 (34.1%) | 2449 (38.6%) |
South | 479 (14.0%) | 269 (11.8%) | 38 (6.0%) | 786 (12.4%) |
AIDS diagnosis, n(%) | ||||
Yes | 336 (9.8%) | 156 (6.8%) | 43 (6.8%) | 535 (8.4%) |
CD4 count cells/mm3, n(%) | ||||
≤ 300 | 1156 (33.8%) | 580 (25.4%) | 172 (27.0%) | 1908 (30.1%) |
301–500 | 810 (23.7%) | 593 (26.0%) | 166 (26.1%) | 1569 (24.8%) |
≥ 501 | 1035 (30.2%) | 861 (37.8%) | 216 (33.9%) | 2112 (33.3%) |
Unknown | 421 (12.3%) | 245 (10.8%) | 83 (13.0%) | 749 (11.8%) |
HIV-RNA viral load, n(%) | ||||
≤ 5000 | 605 (17.7%) | 389 (17.1%) | 114 (17.9%) | 1108 (17.5%) |
5001–10,000 | 208 (6.1%) | 172 (7.5%) | 48 (7.5%) | 428 (6.8%) |
10,001–100,000 | 1222 (35.7%) | 922 (40.5%) | 231 (36.3%) | 2375 (37.5%) |
≥ 100,001 | 1025 (30.0%) | 567 (24.9%) | 179 (28.1%) | 1771 (27.9%) |
Unknown | 362 (10.6%) | 229 (10.0%) | 65 (10.2%) | 656 (10.4%) |
Smoking, n(%) | ||||
No | 2201 (64.3%) | 924 (40.5%) | 188 (29.5%) | 3313 (52.3%) |
Yes | 1092 (31.9%) | 1268 (55.6%) | 413 (64.8%) | 2773 (43.8%) |
Unknown | 129 (3.8%) | 87 (3.8%) | 36 (5.7%) | 252 (4.0%) |
Hepatitis B, n(%) | ||||
Yes | 107 (3.1%) | 59 (2.6%) | 25 (3.9%) | 191 (3.0%) |
HCV Infection, n(%) | ||||
Negative | 2366 (69.1%) | 1549 (68.0%) | 409 (64.2%) | 4324 (68.2%) |
Positive | 410 (12.0%) | 250 (11.0%) | 119 (18.7%) | 779 (12.3%) |
Not tested | 646 (18.9%) | 480 (21.1%) | 109 (17.1%) | 1235 (19.5%) |
Calendar year, n(%) | ||||
2002–2006 | 473 (13.8%) | 313 (13.7%) | 69 (10.8%) | 855 (13.5%) |
2007–2012 | 1113 (32.5%) | 671 (29.4%) | 218 (34.2%) | 2002 (31.6%) |
2013–2016 | 1836 (53.7%) | 1295 (56.8%) | 350 (54.9%) | 3481 (54.9%) |
Follow-up (months) | ||||
Median (IQR) | 26.5 (7.4, 57.1) | 23.4 (4.8, 53.5) | 25.6 (5.6, 54.8) | 25.2 (6.1, 55.6) |